Eton Pharmaceuticals, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
ETON on Nasdaq
Location
21925 W. Field Parkway, Suite 235, Deer Park, IL

Insiders trading volume in the past year

Eton Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sean Brynjelsen President & CEO, Director, 10%+ Owner $48.9M -$3.59M -6.85% Jun 3, 2025
Opaleye Management Inc. 10%+ Owner $45.2M +$205K +0.46% Jun 10, 2025
David Krempa Chief Business Officer $9.23M -$504K -5.18% Jun 12, 2025
James R. Gruber Chief Financial Officer $3.49M -$674K -16.2% Aug 19, 2025
Norbert Riedel Director $563K Jan 3, 2025
Wilson Troutman CFO and Secretary $48.5K Feb 7, 2022
Paul V. Maier Director Jan 3, 2025
Jennifer McKie Adams Director Jan 3, 2025
Charles J. Casamento Director Jan 3, 2025
Ipek Erdogan-Trinkaus Chief Commercial Officer Dec 2, 2024

Recent Insider Transactions by Companies or Individuals for Eton Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.